Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.65 +0.13 (+0.44%)
At close: Sep 30, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Revenue (2014 - 2026)

Updated

Lakefront Biotherapeutics' Revenue came in at $14.09 million for the quarter ended Jun 30, 2026, down 80.9% from $73.94 million a year earlier but up 85.7% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Revenue (2014 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Lakefront Biotherapeutics reported Revenue of $1.15 billion, up 210.3% year-over-year; for the year ended Dec 31, 2025, it was $1.26 billion, up 321.2% from the prior year.

  • Revenue has increased in each of the last three years, with a five-year compound annual growth rate of 18.1% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Revenue was $298.35 million in the year ended Dec 31, 2024 (+15.7%), $257.93 million in the year ended Dec 31, 2023 (+1.4%), $254.27 million in the year ended Dec 31, 2022 (-8.3%) and $277.37 million in the year ended Dec 31, 2021 (-49.2%).
  • The five-year range for quarterly Revenue is -$172.33 million (the quarter ended Dec 31, 2022) to $1.05 billion (the quarter ended Dec 31, 2025).
  • Year-over-year, Revenue increased in two of the last six quarters, with an average decline of 22.2%.
  • The fastest year-over-year change in Revenue over five years came in the quarter ended Sep 30, 2024 (growth of 168.5%), and the weakest in the quarter ended Dec 31, 2024 (a decline of 93.2%).
  • Business Quant data shows LKFT's Revenue at $7.59 million (quarter ended Mar 31, 2026), $1.05 billion (quarter ended Dec 31, 2025) and $83.15 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.31 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 16.99 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.38 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.33 Bn
10 Lakefront Biotherapeutics 1.95 Bn 1.95 Bn 3.51 Mn 14.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.09 Mn
Mar 31, 2026 7.59 Mn
Dec 31, 2025 1.05 Bn
Sep 30, 2025 83.15 Mn
Jun 30, 2025 73.94 Mn
Mar 31, 2025 78.87 Mn
Dec 31, 2024 40.07 Mn
Sep 30, 2024 178.84 Mn
Jun 30, 2024 -27.06 Mn
Mar 31, 2024 67.82 Mn
Dec 31, 2023 585.10 Mn
Sep 30, 2023 66.60 Mn
Jun 30, 2023 65.36 Mn
Mar 31, 2023 62.87 Mn
Dec 31, 2022 -172.33 Mn
Sep 30, 2022 137.29 Mn
Jun 30, 2022 146.88 Mn
Mar 31, 2022 153.03 Mn
Dec 31, 2021 -95.54 Mn
Sep 30, 2021 374.90 Mn
API Access

Lakefront Biotherapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=LKFT&period=max&api_key=YOUR_API_KEY